Metronidazole pulsatile - Advancis

Drug Profile

Metronidazole pulsatile - Advancis

Alternative Names: Metronidazole PULSYS™; Pulsatile metronidazole; PULSYS™-enhanced metronidazole

Latest Information Update: 15 May 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Advancis Pharmaceutical
  • Class Antibacterials; Antiprotozoals; Nitroimidazoles; Radiosensitisers; Small molecules
  • Mechanism of Action DNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Bacterial infections

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 15 May 2007 Discontinued - Phase-I/II for Bacterial infections in USA (PO)
  • 20 Aug 2004 Phase-I/II clinical trials in Bacterial infections in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top